• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure

    4/9/26 5:11:27 PM ET
    $LMRI
    Medical Specialities
    Health Care
    Get the next $LMRI alert in real time by email
    8-K
    false 0002071288 0002071288 2026-04-08 2026-04-08
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of report (Date of earliest event reported): April 8, 2026

     

     

    Lumexa Imaging Holdings, Inc.

    (Exact Name of Registrant as Specified in its Charter)

     

     

     

    Delaware   001-43010   41-2605845
    (State or Other Jurisdiction
    of Incorporation)
     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    4200 Six Forks Road  
    Suite 1000  
    Raleigh, North Carolina   27609
    (Address of Principal Executive Offices)   (Zip Code)

    (919) 763-1100

    (Registrant’s telephone number, including area code)

    Not applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol

     

    Name of each exchange
    on which registered

    Common Stock, $0.001 par value per share   LMRI   The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 7.01.

    Regulation FD Disclosure.

    On April 8, 2026, Lumexa Imaging Holdings, Inc. (the “Company”) held a meeting and site visit where the Company reiterated its previously disclosed full year 2026 guidance.

    The information furnished pursuant to Item 7.01 of this report shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered “filed” under the Exchange Act or incorporates it by reference into a filing under the Securities Act of 1933 or the Exchange Act.

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        LUMEXA IMAGING HOLDINGS, INC.
        By:  

    /s/ J. Anthony Martin

    Date: April 9, 2026     Name:   J. Anthony Martin
        Title:   Chief Financial Officer
    Get the next $LMRI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LMRI

    DatePrice TargetRatingAnalyst
    2/9/2026$23.00Outperform → Strong Buy
    Raymond James
    1/5/2026$23.00Overweight
    Analyst
    1/5/2026$23.00Buy
    Jefferies
    1/5/2026$22.00Overweight
    Wells Fargo
    1/5/2026Outperform
    William Blair
    1/5/2026$23.00Outperform
    Raymond James
    1/5/2026$23.00Outperform
    Leerink Partners
    1/5/2026$22.00Buy
    Deutsche Bank
    More analyst ratings

    $LMRI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lumexa Imaging Holdings upgraded by Raymond James with a new price target

    Raymond James upgraded Lumexa Imaging Holdings from Outperform to Strong Buy and set a new price target of $23.00

    2/9/26 8:16:45 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Analyst initiated coverage on Lumexa Imaging Holdings with a new price target

    Analyst initiated coverage of Lumexa Imaging Holdings with a rating of Overweight and set a new price target of $23.00

    1/5/26 9:16:52 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Jefferies initiated coverage on Lumexa Imaging Holdings with a new price target

    Jefferies initiated coverage of Lumexa Imaging Holdings with a rating of Buy and set a new price target of $23.00

    1/5/26 8:58:21 AM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    SEC Filings

    View All

    SEC Form 10-Q filed by Lumexa Imaging Holdings Inc.

    10-Q - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    5/12/26 4:15:47 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    5/12/26 4:08:46 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form DEFA14A filed by Lumexa Imaging Holdings Inc.

    DEFA14A - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    4/28/26 4:37:06 PM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York

    RALEIGH, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the formation of a strategic joint venture with Hospital for Special Surgery (HSS), world leader in musculoskeletal health. The collaboration represents Lumexa Imaging's ninth joint venture and further strengthens the company's presence in New York—one of the nation's largest healthcare markets. Lumexa Imaging and HSS plan to expand access to advanced outpatient imaging services across the New York City metro area, bringing high-quality, convenient care closer to patients and referring providers. This announcement reflects co

    6/2/26 7:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Announces First Quarter 2026 Results

    RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced results for the first quarter ended March 31, 2026, and reiterated full year 2026 guidance.  "In Q1, we delivered several meaningful achievements to kick off a year of executing on our strategic priorities," said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. "We continued to drive strong growth in same-center advanced imaging volumes and our de novo centers are ramping according to our plans." "We are also announcing tonight four additional Lumexa Imaging centers including two strategic tuck-in acquisitions plus tw

    5/12/26 4:07:00 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers

    RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the addition of four new locations in 2026 as part of its continued execution against a disciplined, multi-channel growth strategy. The new centers are located in Spartanburg, South Carolina; Concord, North Carolina; Wexford, Pennsylvania; and Niceville, Florida. Two of the new locations were added through acquisitions with Lumexa Imaging's joint venture partners, Advocate Health and UPMC, further advancing Lumexa Imaging's strategy to expand in high-growth markets through partnerships with leading health systems. With these tw

    5/12/26 4:05:00 PM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Brodnax Brett bought $253,750 worth of shares (35,000 units at $7.25), increasing direct ownership by 130% to 62,027 units (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    5/21/26 4:20:16 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Director Cooper Henry Lee bought $223,113 worth of shares (30,000 units at $7.44) (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    5/18/26 4:12:52 PM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Brodnax Brett bought $253,750 worth of shares (35,000 units at $7.25), increasing direct ownership by 130% to 62,027 units (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    5/21/26 4:20:16 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Director Cooper Henry Lee bought $223,113 worth of shares (30,000 units at $7.44) (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    5/18/26 4:12:52 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Principal Accounting Officer Walker James Edward Jr. was granted 12,414 shares, increasing direct ownership by 252% to 17,346 units (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    2/27/26 5:40:01 PM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Financials

    Live finance-specific insights

    View All

    Lumexa Imaging Announces First Quarter 2026 Results

    RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced results for the first quarter ended March 31, 2026, and reiterated full year 2026 guidance.  "In Q1, we delivered several meaningful achievements to kick off a year of executing on our strategic priorities," said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. "We continued to drive strong growth in same-center advanced imaging volumes and our de novo centers are ramping according to our plans." "We are also announcing tonight four additional Lumexa Imaging centers including two strategic tuck-in acquisitions plus tw

    5/12/26 4:07:00 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date

    RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET. The live audio webcast will be available in the Investor Relations section of the Company's website at ir.lumexaimaging.com. A replay of the webcast will be available for approximately one year. About Lumexa Imaging Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team member

    4/28/26 4:15:00 PM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Leadership Updates

    Live Leadership Updates

    View All

    Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

    RALEIGH, N.C., April 20, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the appointment of Kyle Lynch as its new Chief Growth Officer (CGO). Lynch joins the executive leadership team to lead the company's enterprise growth strategy, with responsibility for expanding Lumexa Imaging's platform through joint ventures, acquisitions, and de novo development. In this role, Lynch will oversee the full growth lifecycle, including opportunity origination, transaction execution, and post-close value realization, with a focus on driving sustainable, profitable growth and maximizing return on invested capita

    4/20/26 7:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Middleby Appoints Glenn Eisenberg To Board of Directors

    The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,

    3/6/26 7:00:00 AM ET
    $LH
    $LMRI
    $MIDD
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials